MYCN and neuroblastoma: Genetic risk factors previously identified in primary NB include larger chromosomal aberrations, such as amplification of the MYCN oncogene, 11q-deletion, 1p-deletion, and 17q-gain3, as well as activating mutations in ALK encoding anaplastic lymphoma kinase4–8.